BA
GEN

Boston Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Boston Advisors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-70,865
Closed -$505K – 696
2015
Q1 		$505K Buy
+70,865
New +$534K 0.02% 458

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Boston Advisors's GEN Position: Q2 2015 in Review

Boston Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q2 2015, closing a stake of 70,865 shares — an estimated $505K sold.

Boston Advisors first reported a position in GEN in Q1 2015 and held it in 1 quarter. The position peaked at $505K in Q1 2015. 78 funds tracked by Wall St. Rank hold GEN as of Q2 2015.

  • Boston Advisors reported no remaining Genesis Healthcare, Inc. position as of Q2 2015 after selling out during the quarter.
  • Boston Advisors sold 70,865 Genesis Healthcare, Inc. shares in Q2 2015, an estimated $505K.
  • Boston Advisors first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 1 quarter.
  • Boston Advisors's Genesis Healthcare, Inc. position peaked at $505K in Q1 2015.
  • 78 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2015.

Based on Boston Advisors's 13F filing for Q2 2015, filed 22 Jul 2015.